Moreover, interactions between immune checkpoints and their ligands (e.g., PD-1/PD-L1 and CTLA-4/CD86) are further involved in the metabolic reprogramming of tumor cells and immune cells [32]. The gene discussed is CD86; the disease is neoplasm.